Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKesson
Colorcon
Medtronic
Moodys

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR MYCOSTATIN


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Mycostatin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00942526 ↗ Oral Anti-Infective Agent for Esophageal Anastomotic Leakage Unknown status National Taiwan University Hospital Phase 2 2009-06-01 Anastomotic leakage is still to be a major cause of considerable morbidity and mortality after esophagectomy and gastric pull up for esophageal carcinoma. Risk factor analyses of anastomotic leakage, including blood supply, graft tension, and comorbidity, have been performed, but few studies have produced strategies that have improved operative results. This study will be performed to identify prognostic variables that might be used to develop a strategy for optimizing outcomes after esophagogastrectomy.
NCT01495039 ↗ Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients Completed Policlinico Hospital Phase 4 2008-11-01 Purpose. Oral chemoprophylaxis has been advocated to reduce the incidence of Candida colonization and infection. However, Candida prophylaxis in intensive care unit (ICU) is still a matter of debate. Methods. Randomized, single-center trial studying single drug (nystatin) versus control in surgical ICU patients. Multiple-site testing for fungi were performed in each patient at ICU admission (T0) and subsequently every 3 days (T3, T6, T9…). The primary evaluation criterion was the time course of colonization index (CI) during ICU stay.
NCT02166450 ↗ Effects of Denture-Related Stomatitis on Blood Pressure in Denture Wearers Unknown status Jagiellonian University 2011-10-01 The aim of this study is to evaluate the influence of presence of oral fungal infection, which leads to denture-related stomatitis, on blood pressure, endothelial function and immune cell phenotype in patients wearing dentures.
NCT03390374 ↗ Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants Completed Dr Cipto Mangunkusumo General Hospital Phase 4 2010-10-01 This study determines the effectiveness of oral nystatin as prophylaxis in order to prevent systemic fungal infection in very low birth weight preterm neonates. 47 participants received oral nystatin and 48 participants received sterile water as part of oral hygiene.
NCT03862079 ↗ Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics Withdrawn National Cancer Institute (NCI) Phase 2 2020-06-01 This phase II trial studies how well a fecal microbiota transplant with or without total gut decontamination works in preventing graft versus host disease in patients exposed to broad-spectrum antibiotics. Fecal microbiota transplantation is the administration by enema of fecal matter (stool) that includes helpful bacteria from a normal, healthy donor. Total gut decontamination uses antibiotics to remove/reduce the amount of bacteria in the digestive system. It is not yet known if a fecal microbiota transplant with or without total gut decontamination works better in preventing graft versus host disease compared to standard immunosuppressive therapies (therapies that lower the normal function of the immune system).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mycostatin

Condition Name

Condition Name for Mycostatin
Intervention Trials
Denture Stomatitis 1
Fungal Infections Systemic 1
Fungal Prophylaxis 1
Graft-versus-host Disease Prevention 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Mycostatin
Intervention Trials
Birth Weight 1
Graft vs Host Disease 1
Stomatitis, Denture 1
Sepsis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mycostatin

Trials by Country

Trials by Country for Mycostatin
Location Trials
United States 2
Poland 1
Italy 1
Taiwan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Mycostatin
Location Trials
New York 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mycostatin

Clinical Trial Phase

Clinical Trial Phase for Mycostatin
Clinical Trial Phase Trials
Phase 4 2
Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Mycostatin
Clinical Trial Phase Trials
Unknown status 2
Completed 2
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mycostatin

Sponsor Name

Sponsor Name for Mycostatin
Sponsor Trials
Jagiellonian University 1
Dr Cipto Mangunkusumo General Hospital 1
National Cancer Institute (NCI) 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Mycostatin
Sponsor Trials
Other 6
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
AstraZeneca
Merck
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.